Inogen, Inc. (INGN)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Inogen, Inc. currently loses $4.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 4
in 55 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
About Inogen, Inc.
Inogen, Inc. is a NASDAQ-listed healthcare company focused on respiratory medical devices, designing, fabricating, and distributing oxygen concentration equipment that provides continuous oxygen support for people managing persistent respiratory conditions. In FY2025, it generated $348.7 million in revenue through portable and stationary oxygen systems, ventilators, and related accessories.
Today's Snapshot
So far today, INGN is trading 1.9% lower at 5.17, in line with a weaker sector. INGN is trading within 0.3% of its 52-week low of 5.16.
Trading Volume
Below 10d avg (235.1K)
141K
vs S&P 500 Today
Underperforming Market
-1.24%
Updated: September 10, 2026 at 19:05 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$5.36 - $6.54Sell
- RSI (14)28.40Buy
- Stochastic %K (14, 3, 3)8.43Buy
- MACD Level (12, 26)-0.23Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.